期刊文献+

间接比例法检测结核杆菌药物敏感性试验影响因素探讨 被引量:1

The Proportion of Indirect Detection of Mycobacterium Tuberculosis Drug Susceptibility Testing of Factors
下载PDF
导出
摘要 目的:探讨间接比例法检测结核杆菌药物敏感性试验的影响因素。方法:通过对我室2009、2010年两次参加国家结核病参比室组织的结核杆菌药物敏感试验室间质评的结果进行比较与分析,找出影响实验成败的关键因素包括含药培养基配制的质量控制、实验过程的规范化、环境温度的实时监测、结果观察及判断等等,为以后的实验提供技术支持。结果:2010年与国家结核病参比室的药敏结果符合率比2009年有较大的提高。结论:培养基的质量、培养的温度和操作人员的技术娴熟程度均会影响药敏试验结果。 Objective:To explore the influence of indirect proportion method in testing Mycobacterium tuberculosis.Methods:Mycobacterium tuberculosis drug susceptibility testing results were compared and analyzed to identify the key factors of success or failure of experiments,including preparation of the quality of the drug-containing medium control,experimental process of standardization,real-time monitoring of the ambient temperature,the results of observations and judgments,etc.Results:2010 national TB reference room with susceptibility results consistent with a greater rate than the increase in 2009.Conclusion:The quality of the medium,culture temperature and skilled operators will affect the degree of susceptibility test results.
出处 《医学理论与实践》 2011年第10期1121-1123,共3页 The Journal of Medical Theory and Practice
基金 国家第五轮全球基金耐多药结核病防治项目
关键词 间接比例法 结核杆菌 药物敏感试验 影响因素 Indirect proportion method Mycobacterium tuberculosis Drug sensitivity test Factors
  • 相关文献

参考文献2

二级参考文献4

共引文献18

同被引文献20

  • 1包洪,于庭,印璞,刘爱忠,张吉平.中国部分地区结核分支杆菌耐利福平、异烟肼和链酶素耐药基因的检测[J].中国实验诊断学,2007,11(2):232-234. 被引量:8
  • 2中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010.25-52.
  • 3World Health Organazation. Global tuberculosis report 2013 [ M ]. Geneva : World Health Organization,2013.
  • 4Hu Y, Hoffner S, Jiang W, et al. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased muhidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study[ J]. BMC Infect Dis, 2010, 10(43) :1-8.
  • 5[ Van Deun A, Wright A, Zignol M, et al. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories[ J ]. Int J Tuberc Lung Dis, 2011, 15 (1) : 116-124.
  • 6Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis[ J]. Respir Res, 2001, 2 (3) : 164- 168.
  • 7Jureen P, Engstrand L, Eriksson S, et al. Rapid detection of rifampin resistance in Mycobaeterium tuberculosis by pyrosequencing technology[ J]. J Clinl Microbiol, 2006, 44(6) : 1925 -1929.
  • 8Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance [ J ]. N Engl J Med,2010,363 ( 11 ) : 1005-1015.
  • 9Luo T, Jiang L, Sun W, et al. Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis[ J]. J Clinl Microbiol, 2011,49 (9) : 3132-3138.
  • 10Trampuz A, Piper KE, Steckelberg JM, et al. Effect of gamma irradiation on viability and DNA of Staphylococcus epidermidis and Escherichia coli [ J]. J Med Microbiol, 2006, 55 (9) : 1271- 1275.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部